Mehabe score: 4 G Factor: 4 Piotski Score: 8 The stock has a rating . The mehabe team score is reflective of its fundamental and technical merits. A rating above 8 is considered good buy. The stock has a G-Factor of 4 and Piotski score of 8.
Description
Crestchem is primarily involved in manufacturing of Nutrition- Chemical Products.Site:526269
Market Cap:
Rs 11.8 cr
Price:
39.2
Trading pe:
20.6x
Book-value:
3.07/share
Div yield:
0.00 %
Earning yield:
5.77%
Face-value:
10.0/share
52week high:
74.75
52week low:
10.47
Technical Analysis
Stock trades at 39.2, above its 50dma 36.17. It also trades above its 200dma 34.02. The stock remains bullish on techicals
The 52 week high is at 74.75 and the 52week low is at 10.47
Price Chart
P/E Chart
Sales and Margin
Strengths
– is almost debt free.
– has a good return on equity (ROE) track record: 3 Years ROE 38.71%
Weakness
– Stock is trading at 12.77 times its book value
-Though the company is reporting repeated profits, it is not paying out dividend
-Promoter holding is low: 31.59%
Competition
– The industry trades at a mean P/E of 28.4x. Pidilite Inds. trades at the industry’s max P/E of 95.82x. 526269 trades at a P/E of 20.6x
– Industry’s mean G-Factor is 3.6 while the mean Piotski score is 8.0. 526269 has a G-Factor of 4 and Piotski scoreof 8.
– Average 1 month return for industry is 4.0%. The max 1- month return was given by Crestchem: a return of 17.57 %
Quarterly Results
Sales for period ended Mar 2021 is Rs 2.54 cr compared to Rs 2.3 cr for period ended Mar 2020, a rise of 10.4%
Operating Profits reported at Rs 0.3 cr for period ended Mar 2021 vis-vis 0.19 for period ended Mar 2020 .
Operating Margins expanded 355.0 bps for period ended Mar 2021 vis-vis Mar 2020 .
The EPS for Mar 2021 was Rs 0.93 compared to Rs 0.17 for previous quarter ended Dec 2020 and Rs 0.6 for Mar 2020
Profit & Loss Statement
Profit&Loss Comments
Company reported sales of Rs 7.64 cr for period ended Mar 2021 vis-vis sales of Rs 6.15 cr for the period ended Mar 2020, a healthy growth of 19.5%. The 3 year sales cagr stood at 434.6%.
Operating margins shrank to 8.77% for period ended Mar 2021 vis-vis 9.11% for period ended Mar 2020, contraction of 34.0 bps.
Net Profit reported at Rs 0.57 cr for period ended Mar 2021 vis-vis sales of Rs 0.44 cr for the period ended Mar 2020, rising 0%.
Balance Sheet Statement
Cash Flow Statement
Cash Flow comments
Sales Growth
Profit Growth Statement
Profit Growth Statement
Stock Price CAGR
Return of Equity
General Comments
– The company has improved its Return on Equity (RoE) metric. The RoE on Last Year basis was 62.0% compared to 39.0% over the last 3 Years. – The stock has given a return of 273% on a 1 Year basis vis-vis a return of 48% over the last 3 Years. – The compounded sales growth on a TTM bassis is 24% vis-vis a compounded sales growth of 435% over the last 3 Years. – The compounded profit growth on a TTM basis is 30% vis-vis a compounded profit growth of 71% over the last 3 Years.
Ratios
Shareholding Pattern
– Public shareholding has remained largely constant. The Mar 2021 public holding stood at 68.28% vis-vis 68.88% for Dec 2020
Conclusion
– is almost debt free.
– has a good return on equity (ROE) track record: 3 Years ROE 38.71% – Stock is trading at 12.77 times its book value
-Though the company is reporting repeated profits, it is not paying out dividend
-Promoter holding is low: 31.59%
